Pharmacokinetics of Tasimelteon Alone and in Combination With a CYP3A4 Inhibitor, Ketoconazole, or a CYP3A4 Inducer, Rifampin.

This study has been completed.
Information provided by (Responsible Party):
Vanda Pharmaceuticals Identifier:
First received: June 28, 2012
Last updated: February 14, 2014
Last verified: February 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2012
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)